Publicações

Publications

Confira as publicações associadas ao LBCAF

Check out the LBCAF associated publications

PubMed

Confira as publicações associadas ao LBCAF no PubMed

PubMed

Confira as publicações associadas ao LBCAF no PubMed

Clique Aqui

PubMed

Check out the LBCAF associated publications on PubMed

PubMed

Check out the publications associated with the LBCAF on PubMed

Click here

Google Scholar

Confira as publicações associadas ao LBCAF no Google Scholar

Google Scholar

Confira as publicações associadas ao LBCAF no Google Scholar

Clique Aqui

Google Scholar

Check out the LBCAF associated publications on Google Scholar

Google Scholar

Check out the publications associated with the LBCAF on Google Scholar

Click here

Últimos 10 anos

Last 10 years

P2X7-NEK7-NLRP3 Axis Drives Cardiac Inflammation and Fibrosis in Isoproterenol-Induced Cardiac Remodeling in Mice

Acta Physiol (Oxf). 2026 Aug;242(8):e70280. doi: 10.1111/apha.70280. PMID: 42449490.

Increased macrophages contribute to thyroid hormone-induced cardiac alterations in mice

Acta Physiol (Oxf). 2025 Mar;241(3):e70011. doi: 10.1111/apha.70011. PMID: 39918422

Cardiac hypertrophy that affects hyperthyroidism occurs independently of the NLRP3 inflammasome

Pflugers Arch. 2024 Jul;476(7):1065-1075. doi: 10.1007/s00424-024-02965-6. Epub 2024 Apr 29. PMID: 38679646

Beta-arrestins in the context of cardiovascular diseases: Focusing on angiotensin II type 1 receptor (AT1R)

Cell Signal. 2022 Apr;92:110253. doi: 10.1016/j.cellsig.2022.110253. Epub 2022 Jan 22. PMID: 35077849

Beta-arrestin 2 mediates cardiac hypertrophy induced by thyroid hormones via AT1R

J Cell Physiol. 2021 Jun;236(6):4640-4654. doi: 10.1002/jcp.30187. Epub 2020 Dec 20. PMID: 33345322

Angiotensin-(1-7) prevents T3-induced cardiomyocyte hypertrophy by upregulating FOXO3/SOD1/catalase and downregulating NF-ĸB

J Cell Physiol. 2021 Apr;236(4):3059-3072. doi: 10.1002/jcp.30069. Epub 2020 Sep 23. PMID: 32964425

The endocrinological component and signaling pathways associated to cardiac hypertrophy

Mol Cell Endocrinol. 2020 Dec 1;518:110972. doi: 10.1016/j.mce.2020.110972. Epub 2020 Aug 7. PMID: 32777452

Ubiquitin proteasome system (UPS) activation in the cardiac hypertrophy of hyperthyroidism

Mol Cell Endocrinol. 2019 Aug 1;493:110451. doi: 10.1016/j.mce.2019.110451. Epub 2019 May 18. PMID: 31112742

Angiotensin-(1-7) reduces cardiac effects of thyroid hormone by GSK3b/NFATc3 signaling pathway

Clin Sci (Lond). 2018 Jun 5;132(11):1117-1133. doi: 10.1042/CS20171606. Print 2018 Jun 14. PMID: 29685981

Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice

Heart Vessels. 2018 Jun;33(6):671-681. doi: 10.1007/s00380-017-1101-5. Epub 2017 Dec 7. PMID: 29218410

AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes

Pflugers Arch. 2018 Mar;470(3):549-558. doi: 10.1007/s00424-017-2088-6. Epub 2017 Nov 25. PMID: 29178049

S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone

J Mol Med (Berl). 2017 Jun;95(6):671-682. doi: 10.1007/s00109-017-1511-y. Epub 2017 Feb 4. PMID: 28161820

MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone

J Cell Physiol. 2017 Dec;232(12):3360-3368. doi: 10.1002/jcp.25781. Epub 2017 Mar 28. PMID: 28063219